Enhabit (NYSE:EHAB) Releases FY 2025 Earnings Guidance

Enhabit (NYSE:EHAB) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 0.410-0.510 for the period, compared to the consensus earnings per share estimate of 0.290. The company issued revenue guidance of $1.1 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion.

Analyst Upgrades and Downgrades

Several analysts have commented on EHAB shares. Jefferies Financial Group upgraded shares of Enhabit from a “hold” rating to a “buy” rating and raised their price objective for the stock from $8.25 to $9.50 in a report on Monday, December 9th. Leerink Partners restated a “market perform” rating and set a $8.00 price target (down from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $8.75.

Enhabit Stock Up 1.0 %

NYSE:EHAB traded up $0.08 during trading hours on Wednesday, reaching $8.55. 306,118 shares of the company traded hands, compared to its average volume of 276,636. Enhabit has a 1 year low of $6.85 and a 1 year high of $11.74. The stock has a market capitalization of $430.13 million, a P/E ratio of -3.69 and a beta of 1.83. The business’s 50-day moving average price is $8.16 and its two-hundred day moving average price is $7.90. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85.

Enhabit (NYSE:EHAB) last announced its quarterly earnings results on Wednesday, March 5th. The company reported $0.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.03). Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. Analysts predict that Enhabit will post 0.22 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Stuart M. Mcguigan acquired 15,000 shares of the stock in a transaction that occurred on Tuesday, December 10th. The shares were bought at an average price of $8.81 per share, for a total transaction of $132,150.00. Following the completion of the transaction, the director now directly owns 46,810 shares in the company, valued at approximately $412,396.10. This trade represents a 47.15 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Jeffrey Bolton bought 4,000 shares of the business’s stock in a transaction on Thursday, December 12th. The stock was bought at an average cost of $8.69 per share, with a total value of $34,760.00. Following the transaction, the director now owns 98,144 shares in the company, valued at $852,871.36. This trade represents a 4.25 % increase in their position. The disclosure for this purchase can be found here. 1.90% of the stock is owned by company insiders.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.